Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Updated development status of Oxygent in China

March 19, 2007

Neose cleared to begin U.S. development of NE-180

March 19, 2007

C1-INH meets primary endpoint in acute HAE study

March 16, 2007

Recent Lilly and Merck patents describe new antidiabetic agents

March 16, 2007

Atorvastatin may reduce cardiovascular events more than simvastatin

March 16, 2007

IND filing for pivotal study of improved octreotide formulation

March 15, 2007

ObeCure begins phase II study for OBE-101 to prevent Zyprexa weight gain

March 15, 2007

Novel therapeutic strategies for metabolic disorders described in recent patents

March 15, 2007

Infuse Bone Graft approved for oral maxillofacial and dental regeneration

March 14, 2007

Depomed seeks clearance to begin phase II studies of Gabapentin GR

March 14, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...